Smad7 Is A Promising Therapeutic Target On The Tgf-Beta Pathway To Prevent Or Reverse New-Onset Type 1 DiabetesSirlene R. Cechin, Omar Lopez-Ocejo,Camillo Ricordi,Peter BuchwaldDIABETES（2015）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
